Effect of Continuous Adductor Canal Block Versus Continuous Adductor Canal Block With Additional Infiltration Between The Popliteal Artery and Capsule of The Knee (IPACK) After Arthroscopic Knee Surgeries
Launched by AIN SHAMS UNIVERSITY · Jan 30, 2025
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring two different ways to manage pain after knee surgery. Specifically, it compares a method called Continuous Adductor Canal Block (CACB) to a combination of CACB and an additional injection called the Infiltration between the Popliteal Artery and Capsule of the Knee (IPACK). Both techniques aim to help reduce pain following arthroscopic knee surgeries, which are often performed to repair ligaments such as the anterior cruciate ligament (ACL) and posterior cruciate ligament (PCL).
To participate in this trial, individuals should be between 21 and 65 years old, in generally good health (Classes I to II according to the American Society of Anesthesiologists), and scheduled for elective knee surgery. However, those with certain medical conditions, allergies to study medications, or significant health issues may not be eligible. Participants can expect to receive either of the two pain management techniques and will be closely monitored to see which method works better for pain relief after surgery. This study is currently recruiting participants, and their involvement could help improve pain management for future knee surgery patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age from 21 to 65 years.
- • Both sexes.
- • American Society of Anesthesiologists (ASA) Physical Status Class I to II.
- • Patients with successful spinal anesthesia.
- • Patients scheduled for elective arthroscopic knee surgery for anterior cruciate ligament (ACL) and posterior cruciate ligament (PCL) repair.
- Exclusion Criteria:
- • Declining to give written informed consent.
- • History of allergy to the medications used in the study.
- • Contraindications to regional anesthesia (including coagulopathy and local infection).
- • Polytrauma patients having lower limb fractures.
- • Patients with pre-existing myopathy or neuropathy on the operating limb.
- • Patients with diabetes mellitus.
- • Psychiatric disorder.
- • Morbid obesity \[body mass index (BMI) \> 45kg/m2\].
- • Complicated Surgery.
About Ain Shams University
Ain Shams University, established in Cairo, Egypt, is a prestigious higher education institution renowned for its commitment to academic excellence and research innovation. As a clinical trial sponsor, the university leverages its extensive resources and expertise in various medical and scientific disciplines to advance healthcare through rigorous research initiatives. With a focus on ethical practices and adherence to regulatory standards, Ain Shams University aims to contribute to the development of new therapies and improve patient outcomes, fostering collaboration among researchers, healthcare professionals, and industry partners in the pursuit of medical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported